Symphony Asset Management’s Novo Nordisk NVO Stock Holding History

Symphony Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-30,588	Closed	-$888K	–	414
2015 Q4	$888K	Sell	30,588 -14,720	-32%	-$407K	0.1%	204
2015 Q3	$1.23M	Buy	45,308 +7,542	+20%	+$214K	0.15%	157
2015 Q2	$1.03M	Sell	37,766 -3,086	-8%	-$86.8K	0.13%	176
2015 Q1	$1.09M	Buy	+40,852	New	+$941K	0.13%	173
2014 Q1	–	Sell	-24,980	Closed	-$461K	–	455
2013 Q4	$461K	Buy	+24,980	New	+$435K	0.03%	300

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Symphony Asset Management's NVO Position: Q1 2016 in Review

Symphony Asset Management sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 30,588 shares — an estimated $888K sold.

Symphony Asset Management first reported a position in NVO in Q4 2013 and held it in 5 quarters. The position peaked at $1.23M in Q3 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Symphony Asset Management reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
Symphony Asset Management sold 30,588 Novo Nordisk shares in Q1 2016, an estimated $888K.
Symphony Asset Management first reported a position in Novo Nordisk in Q4 2013 and held it in 5 quarters.
Symphony Asset Management's Novo Nordisk position peaked at $1.23M in Q3 2015.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Symphony Asset Management's 13F filing for Q1 2016, filed 13 May 2016.